Found: 3
Select item for more details and to access through your institution.
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1396603
- By:
- Publication type:
- Article
Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 356, doi. 10.3390/vaccines12040356
- By:
- Publication type:
- Article
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1010105
- By:
- Publication type:
- Article